Skip to content

Dr Ken Gillman

Critical independent evaluations in psycho-pharmacology

  • Consider a Donation
output-onlinepngtools_3_

MENU

  • Home Page
  • Introduction to PsychoTropical
  • Serotonin Toxicity
  • Depressive Illness
    • Access to MAOIs when not available in your country
  • Patient Stories
  • MAOIs Antidepressants
  • General Pharmacology
  • TCA
  • Mood Stabilisers
  • Bias In Science
  • Odds & Ends
  • Medical Legal Consultations
  • Publications
  • Media
  • Contact Dr Gillman

Presentation and Typeface

  • Post author:Ken Gillman
  • Post category:Odds & Ends
  • Post published:2 August 2020
  • Post last modified:26 November 2023

These commentaries are based on Dr Gillman’s peer reviewed scientific papers, see Publications, A foolish consistency is the hobgoblin of little minds, adored by little statesmen and philosophers and divines. Self-reliance…

Continue ReadingPresentation and Typeface

A Comment on Dreyers English

  • Post author:Ken Gillman
  • Post category:Odds & Ends
  • Post published:2 August 2020
  • Post last modified:26 November 2023

These commentaries are based on Dr Gillman’s peer reviewed scientific papers, see Publications, A foolish consistency is the hobgoblin of little minds, adored by little statesmen and philosophers and divines. Self-reliance…

Continue ReadingA Comment on Dreyers English

Sugar, alcohol, health and society

  • Post author:Ken Gillman
  • Post category:Odds & Ends
  • Post published:2 May 2020
  • Post last modified:23 November 2021

Summary The more easily available ‘foods’ are, the greater is the likelihood that we will consume more of them. That is such a banal observation that its profound implications and impact…

Continue ReadingSugar, alcohol, health and society

2. Duloxetine: another SNRI myth

  • Post author:Ken Gillman
  • Post category:Antidepressants/SNRIs
  • Post published:29 March 2020
  • Post last modified:26 November 2023

These commentaries are based on Dr Gillman’s peer reviewed scientific papers, see Publications, Duloxetine does not have a ‘badge-engineered’ metabolite derivative to extend its patent, unlike Venlafaxine (Effexor, now out of…

Continue Reading2. Duloxetine: another SNRI myth
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 37
  • Go to the next page

Recent Posts

  • Antidepressants – TCAs vs the rest
    13 November 2005/
    0 Comments
  • Tricyclic antidepressants side effects
    1 March 2020/
    0 Comments
  • [NEW] Important Announcement & Update
    6 July 2022/
    0 Comments
  • Taste, Wine, food, and combinations: Advances, and insights from science
    2 March 2020/
    0 Comments
  • Trump, psychopathy, and the Goldwater rule
    13 January 2021/
    0 Comments
output-onlinepngtools_3_

PsychoTropical is a knowledge and education resource started by Dr Gillman about 20 years ago. It is neither connected with, nor influenced by, any financial backing or interest group of any sort. The opinions expressed relate to Dr Gillman’s special knowledge and expertise as a recognised world-expert in MAOIs and serotonin toxicity.

Top Pages

Contact Dr Gillman

Patient Stories

MAOIs

Top Posts

MAOIs: Introductory Comments
MAOI Diet Info Overview
Gillman’s Antidepressants Algorithm
Swapping From One MAOI To Another

Miscellaneous

Disclosure

© PsychoTropical 2025. All Rights Reserved